PREVENTION OF RESPIRATORY SYNCYTIAL VIRUS INFECTION IN CHILDREN: ACTIVE AND PASSIVE IMMUNIZATION

Authors

  • Maria Clara Barroso Leite Lopes acadêmica de Medicina Centro Universitário Uninovafapi/ AFYA
  • Ian isaias paes landim Ribeiro da Silva acadêmico de medicina centro universitário Uninovafapi / AFYA
  • Luciane Mari Brito Cavalcante acadêmico de medicina centro universitário São Lucas Porto Velho / Afya
  • Cleuma Regina Freitas de Almeida Pontes Acadêmica de Medicina Afya - PALMAS-TO
  • Alexandre Bruno Veras Bogea Cardoso Acadêmico de Medicina instituto educacional superior vale do parnaiba/ afya
  • Ana Lais Namie Lopata Acadêmica de Medicina Unicesumar
  • David Breno Silva Sousa Acadêmico de Medicina instituto de ensino superior vale do parnaíba/ afya (IESVAP)
  • Bruna cordeiro dos Santos Bainha acadêmica de medicina faculdade de medicina de Campos
  • Maria Teresa de Oliveira Paes Landim Graduada em Medicina Universidade de Gurupi (UnirG)
  • Isabela Meneses de Morais Fontana Graduada em Medicina Unigranrio
  • Camila Mendes Costa Carvalho Pós Graduada em Educação para Saúde Hospital Universitário da Universidade Federal do Maranhão- HUUFMA - Unidade Materno Infantil
  • Natália Soella de Souza Campos Acadêmica de Medicina Faculdade de Medicina de Campos - FMC
  • Shirlei de Oliveira Soares Araújo Graduanda em Medicina Unigranrio
  • Tenylle Botelho Fernandes Residente de pediatria HEC - Hospital estadual da criança
  • Matheus Henrique Gomes Pimentel Residente de Pediatria Hospital Geral de Palmas - UFT

DOI:

https://doi.org/10.36557/2674-8169.2024v6n3p2036-2044

Keywords:

Respiratory Syncytial Virus, Bronchiolitis, Disease

Abstract

This article aims to carry out an analysis of the current medical literature on respiratory syncytial virus, discussing its prevention. Respiratory syncytial virus usually starts like a common cold, with symptoms such as runny nose, low-grade fever and cough. The disease can progress to shortness of breath, caused by bronchiolitis, an inflammatory condition of the bronchioles, which are smaller branches of the channels that transport air to the lungs — the bronchi. There are several vaccines under development for respiratory syncytial virus, using different technologies. In May 2023, the United States approved the world's first vaccine against the disease, suitable for the elderly.

Downloads

Download data is not yet available.

References

Hall CB, Weinberg GA, Iwane MK, Blumkin A, Edwards KM, Staat M et al. The burden of respiratory syncytial virus infection in young children. N Engl J Med 2009;360:588-98.

Monteiro AI, Bellei NC, Sousa AR, Santos AM, Weckx LY. Infecções respiratórias em crianças menores de dois anos de idade submetidas à profilaxia com palivizumabe. Rev Paul Pediatr 2014;32:152-8.

Yoshihara S, Kusuda S, Mochizuki H, Okada K, Nishima S, Simões EA; C-CREW Investigators. Effect of palivizumab prophylaxis on subsequent recurrent wheezing in preterm infants. Pediatrics 2013;132:811-8.

Zhou H, Thompson W, Viboud C, Ringholz C, Cheng PY, Steiner C et al. Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993-2008. Clin Infect Dis 2012;54:1427-36.

Published

2024-03-21

How to Cite

Lopes , M. C. B. L., Silva , I. isaias paes landim R. da, Cavalcante, L. M. B., Pontes, C. R. F. de A., Cardoso, A. B. V. B., Lopata , A. L. N., Sousa , D. B. S., Bainha , B. cordeiro dos S., Landim, M. T. de O. P., Fontana, I. M. de M., Carvalho, C. M. C., Campos , N. S. de S., Araújo , S. de O. S., Fernandes, T. B., & Pimentel , M. H. G. (2024). PREVENTION OF RESPIRATORY SYNCYTIAL VIRUS INFECTION IN CHILDREN: ACTIVE AND PASSIVE IMMUNIZATION. Brazilian Journal of Implantology and Health Sciences, 6(3), 2036–2044. https://doi.org/10.36557/2674-8169.2024v6n3p2036-2044

Issue

Section

Systematic Review